Evidano home
Commentary on News

AI Qualitative Analysis in Healthcare: HCV Access

Evidano8 min read

Healthcare researchers often have the data needed to identify access problems, but patient interviews can be slow to transcribe, code, compare, and connect to quantitative findings. AI qualitative analysis in healthcare can help research teams organize those accounts while preserving the context behind percentages. A November 20, 2026 study in PLOS One examined Hepatitis C virus treatment access in Los Angeles County by combining program data from 344 case-residents with interviews involving 10 participants. The study shows why healthcare teams need more than frequency counts: language, cost, transportation, trust, housing instability, and care coordination shaped treatment journeys in different ways. This article explains what the study found, how qualitative analysis clarifies the numbers, and how AI-assisted workflows can help public health, clinical, and UX research teams move from transcripts to defensible themes. Medical content is presented for research and service-design purposes, not diagnosis or individual treatment advice.

Key Takeaways

AI qualitative analysis in healthcare can help researchers connect patient narratives with structured program data, as demonstrated by the November 20, 2026 PLOS One study, Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County: A mixed-methods study.

The Los Angeles County study found that treatment access was shaped by personal, provider, insurance, language, transportation, and healthcare-system barriers, while motivation, family support, provider trust, and adequate coverage helped participants pursue care.

  • Between October 2024 and January 2025, the study examined de-identified program data from 344 case-residents and conducted semi-structured interviews with 10 participants.
  • The study reported that 54% of case-residents experienced barriers, with personal barriers accounting for 43% of specific reported barriers, provider-related barriers for 31%, insurance barriers for 13%, and inadequate medical access for 13%.
  • The study reported that 168 of 344 case-residents, or 49%, had already received HCV treatment, while 176 had not received treatment during the study period.
  • The seven untreated and three treated interview participants described language barriers, cost, transportation, limited information, homelessness, incarceration, drug addiction, long wait times, family support, and provider trust.
  • The authors recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, treatment continuity after incarceration, and fewer insurance restrictions.

What the HCV Study Shows About Healthcare Thematic Analysis

The HCV study shows that healthcare thematic analysis explains why treatment barriers appear in program data. According to the November 20, 2026 PLOS One study, researchers used a convergent parallel mixed-methods design: quantitative and qualitative data were collected during the same period, analyzed separately, and merged during interpretation.

The quantitative component used descriptive frequencies and percentages from a linkage-to-cure program. According to the study authors, inferential analysis was not performed because most specific barrier categories had sample sizes below 15, limiting the robustness of statistical comparisons.

The qualitative component used inductive coding and thematic analysis of interviews with seven untreated and three treated participants. According to the study, team members independently coded transcripts, compared codes in regular meetings, and resolved coding discrepancies collaboratively.

The qualitative evidence added context that percentages alone could not provide. One untreated Spanish-speaking participant told the researchers, "Since I don’t speak 100% English... I didn’t understand anything, " describing how language and unclear medication information contributed to withdrawal from care.

A second participant summarized the information gap by saying, "I hadn’t heard so much about [HCV at the time of my diagnosis]... I don’t really know all that stuff about Hepatitis." These quotations show how thematic analysis can distinguish a lack of motivation from a lack of understandable information.

The study also identified facilitators, including personal motivation, family and community support, trust in medical providers, insurance coverage, knowledge of treatment benefits, and the desire to avoid stigmatization. These themes help public health teams design interventions that respond to both practical barriers and patient priorities.

HCV Treatment Access Findings Snapshot

Date or periodMetricValueImplication for qualitative research
October 2024 to January 2025Case-residents contacted344The study combined a substantial program-data cohort with a smaller interview sample.
October 2024 to January 2025Case-residents reporting treatment barriers54%Researchers needed qualitative data to explain how barriers affected treatment decisions.
October 2024 to January 2025Specific barriers attributed to personal factors43% of 91 case-residents reporting specific barriersPersonal circumstances were the most common reported barrier category.
October 2024 to January 2025Specific barriers attributed to provider-related factors31% of 91 case-residents reporting specific barriersProvider communication, follow-up, and navigation required closer examination.
October 2024 to January 2025Interview participants10, including 7 untreated and 3 treated participantsCross-segment comparison revealed differences between treatment journeys.
2019 to 2023People diagnosed with HCV in Los Angeles County27, 678The study placed the interview findings within a larger county-level access problem.

Implications of AI Qualitative Analysis for Healthcare Research Teams

Healthcare research teams can use AI qualitative analysis to move from recurring patient statements to targeted service and policy decisions. The HCV study indicates that access problems were not explained by a single variable, because language, cost, insurance, transportation, provider interactions, housing, incarceration, and substance use intersected across treatment journeys.

  • Public health teams can compare themes by treatment status, language, insurance type, or service pathway instead of reporting one undifferentiated barrier list.
  • Clinical improvement teams can code provider communication, referral delays, wait times, and follow-up failures to identify where care coordination breaks down.
  • Equity researchers can compare English- and Spanish-language interviews while preserving participant quotations and the context surrounding each code.
  • Program evaluators can connect frequencies from surveys or administrative data with themes from interviews, helping distinguish how often a barrier occurs from how the barrier is experienced.
  • Policy teams can use coded evidence to assess whether recommendations such as patient navigation, translated materials, mobile clinics, or reduced prior authorization address the barriers participants actually described.

According to the November 20, 2026 study, the qualitative sample was exploratory and small, so the findings should guide further research rather than be generalized to every Los Angeles County resident. AI-assisted analysis should therefore support researcher judgment, transparent codebooks, sampling decisions, and human review rather than replace them.

How Evidano Helps With AI Qualitative Analysis in Healthcare

Problem: Healthcare transcripts take too long to organize

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze patient interviews, open-ended surveys, and healthcare documents.

Evidano can ingest interview transcripts, research papers, reports, news, blogs, and spreadsheets, then generate thematic, content, frequency, and cross-segment analyses. Researchers can use Evidano’s features to reduce manual sorting while keeping the research question and analytic framework visible.

Problem: Patient experiences need comparison across groups

Evidano supports cross-segment analysis for comparing groups such as treated and untreated participants, English- and Spanish-language interviews, or different insurance categories.

Researchers can use hierarchical codes and subcodes, word clouds, and co-occurrence networks to inspect relationships among themes such as language, cost, transportation, trust, and treatment motivation.

Problem: Multilingual data can hide important access barriers

Evidano provides transcription with custom dictionaries and PII redaction, plus translation with custom dictionaries, which can help research teams prepare multilingual interview data for analysis.

The November 20, 2026 PLOS One study conducted interviews in English and Spanish, making language-aware processing relevant to the study’s research context. Researchers should still review translated or transcribed material against the original recording when wording affects interpretation.

Problem: Researchers need grounded answers across many files

Evidano provides AI chat over uploaded documents and analyses, allowing research teams to ask focused questions about barriers, facilitators, segments, and supporting quotations.

Evidano encrypts data and does not use customer data to train third-party models, according to the platform’s product information. Healthcare teams should still follow their institutional review board, consent, de-identification, and data-governance requirements.

FAQ: AI Qualitative Analysis in Healthcare

What is AI qualitative analysis in healthcare?

AI qualitative analysis in healthcare is the use of artificial intelligence to organize, code, summarize, compare, and explore interviews, open-ended survey responses, and clinical or public health documents.

The November 20, 2026 HCV study demonstrates why this approach matters: quantitative frequencies showed the scale of barriers, while interviews explained the experiences behind language, cost, transportation, provider, and information barriers.

How many people participated in the Los Angeles County HCV study?

The study used program data from 344 case-residents and interviewed 10 participants between October 2024 and January 2025.

The interview sample included seven untreated participants and three treated participants, according to the November 20, 2026 PLOS One publication.

What were the main barriers to HCV treatment access?

The main barriers were personal circumstances, provider-related problems, insurance, inadequate medical access, language, cost, transportation, limited information, homelessness, incarceration, drug addiction, and long waits for providers.

The study reported that personal barriers represented 43% of specific barriers, provider-related barriers represented 31%, and insurance and inadequate medical access each represented 13% among the 91 case-residents who reported specific barriers.

Why are qualitative interviews important in healthcare access research?

Qualitative interviews are important because they explain how and why people experience barriers that administrative or survey data may only count.

In the HCV study, interviews showed that language and unclear medication information could discourage care, while family support, provider trust, and treatment knowledge could encourage it.

Can AI replace human researchers in healthcare thematic analysis?

AI can accelerate healthcare thematic analysis, but AI should not replace human researchers’ decisions about sampling, interpretation, ethics, context, and validity.

The HCV study used independent coding, researcher meetings, and discrepancy resolution, illustrating the value of human oversight in qualitative analysis.

Conclusion and Next Steps for Healthcare Researchers

The November 20, 2026 HCV access study shows that mixed-methods healthcare research is strongest when statistics and patient narratives are interpreted together. AI qualitative analysis can help teams identify themes, compare segments, preserve quotations, and connect lived experience to program decisions, while researchers remain responsible for ethical interpretation and validation. Evidano provides a practical workflow for analyzing multilingual transcripts, documents, surveys, and cross-segment healthcare data. Try Evidano for free to turn qualitative healthcare data into structured, reviewable research insights.

Topics

  • AI qualitative analysis in healthcare
  • healthcare thematic analysis
  • HCV qualitative research
  • AI analysis of patient interviews
  • qualitative healthcare research

Keep reading

Browse all articles